EHA 2020 | UK CAR-T: changing the landscape of lymphoma treatment
Andrea Kuhnl
Andrea Kuhnl, MD, King’s College Hospital, London, United Kingdom, discusses the impact of CAR T-cell therapy on the treatment of lymphoma patients in the UK as well as potential pitfalls associated with their use. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Related videos
5:56 Detection of ctDNA in patients with MCL and CLL
Constantine Tam
6:23 Molecular classification, biology-based clinical trials and liquid biopsy in lymphoma
Jessica Okosun
8:14 CART19-BE-01: ARI-0001 in CD19+ malignancies
ValentÃn Ortiz-Maldonado
2:59 CD5 and CD7 directed CAR T-cells for pediatric T-cell malignancies
Maksim Mamonkin
4:43 Waldenstrom's macroglobulinemia in the era of immunotherapy
Morie Gertz
